Role of stimulating growth factor 2 and galectin-3 in predicting the ventricular tachyarrhythmias in patients with ischemic cardiomyopathy

Role of stimulating growth factor 2 and galectin-3 in predicting the ventricular tachyarrhythmias in patients with ischemic cardiomyopathy

Aim. To assess the role of stimulating growth factor 2 (ST-2) and galectin-3 in predicting the ventricular tachyarrhythmias (VTA) in patients with coronary artery disease (CAD) and left ventricular ejection fraction (LVEF) <35%.Material and methods. The study included 40 patients (men, 36 (90...

Full description

Saved in:

Bibliographic Details
Main Authors:	T. A. Atabekov, R. E. Batalov, S. I. Sazonova, A. M. Gusakova, S. N. Krivolapov, M. S. Khlynin, S. V. Popov
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2021-05-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	sudden cardiac death ventricular tachyarrhythmia cardioverter-defibrillator 6-minute walk test st-2 galectin-3 left ventricular ejection fraction
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/2676
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Differences in clinical significance of atrial tachyarrhythmias in idiopathic ventricular fibrillation vs Brugada syndrome: A multicenter study
by: Tomofumi Mizuno, MD, et al.
Published: (2024-11-01)

Contemporary medical therapy, sex-specific characteristics, and outcomes of patients with non-ischemic cardiomyopathy: a prespecified interim analysis of the BIO-LIBRA studyResearch in context
by: Valentina Kutyifa, et al.
Published: (2025-08-01)

Importance of blood biomarker determination in the selection of patients with heart failure for cardioverterdefibrillator implantation
by: N. N. Ilov, et al.
Published: (2023-11-01)

Mitochondrial DNA Polymorphisms of Peripheral Blood Mononuclear Cells Associated with Sustained Ventricular Tachycardia in Patients with Cardioverter-Defibrillator Implantation Indications
by: Tariel Atabekov, et al.
Published: (2025-03-01)

Navigating the Uncommon: Case Report of Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) Successfully Managed with Implantable Cardioverter Defibrillator (ICD)
by: Sidhi Laksono Purwowiyoto, et al.
Published: (2024-10-01)

Cardiac resynchronization therapy: potential for arrhythmic risk modification
by: N. N. Ilov, et al.
Published: (2023-06-01)

Subcutaneous cardioverter-defibrillator, patient selection, implantation, postoperative management in the Krasnoyarsk
by: A. V. Prokopenko, et al.
Published: (2022-09-01)

IMPLANTABLE CARDIOVERTER DEFIBRILLATORS ARE THE MAIN MODE FOR SUDDEN CARDIAC DEATH PREVENTION
by: L. A. Bokeria, et al.
Published: (2019-02-01)

A new marker for ventricular tachyarrhythmias in patients with postinfarction left ventricular aneurysm: Big endothelin-1
by: Tufan Çınar, et al.
Published: (2020-02-01)

DX single-lead implantable cardioverter-defibrillator system with a floating atrial dipole: when, to whom, and why?
by: A. V. Prokopenko, et al.
Published: (2023-06-01)

Polymorphisms in the GNAS Gene as Predictors of Ventricular Tachyarrhythmias and Sudden Cardiac Death: Results From the DISCOVERY Trial and Oregon Sudden Unexpected Death Study
by: Heinrich Wieneke, et al.
Published: (2016-12-01)

Ventricular arrhythmias. Ventricular tachycardias and sudden cardiac death. 2020 Clinical guidelines
by: D. S. Lebedev, et al.
Published: (2021-08-01)

Perspectives on the Use of Transthoracic Echocardiography Results for the Prediction of Ventricular Tachyarrhythmias in Patients with Non-ischemic Cardiomyopathy
by: N. N. Ilov, et al.
Published: (2022-07-01)

Incidence of Rapid Rate Non‐Sustained and Sustained Ventricular Tachycardia in Implantable Cardioverter‐Defibrillator Recipients and Its Correlation With Heart Failure Guideline‐Directed Medical Therapy Compliance
by: Muhammad Taha Khan, et al.
Published: (2025-08-01)

Analysis of electrotherapy of cardioverter defibrillators implanted for the primary prevention of sudden cardiac death
by: V. K. Lebedeva, et al.
Published: (2019-08-01)

Clinical and anamnestic predictors of poor long-term prognosis in patients with chronic heart failure and implanted cardioverter-defibrillator
by: Nataliya B. Lebedeva, et al.
Published: (2025-01-01)

Changes of NT-proBNP and sST2 levels for predicting isolated episodes of ventricular tachyarrhythmias and electrical storm in patients with systolic heart failure and various implanted devices
by: A. Zh. Gasparyan, et al.
Published: (2020-12-01)

Fever as a Catalyst for Life‐Threatening Arrhythmias in Brugada Syndrome: A Rare Case of Brugada Syndrome Unmasked in a Young Male
by: Ibrahim Khalil, et al.
Published: (2025-07-01)

Possibilities for predicting ventricular tachyarrhythmias in patients with heart failure with reduced ejection fraction based on surface electrocardiography. First results from a single-center prospective study
by: N. N. Ilov, et al.
Published: (2022-01-01)

The triglyceride-glucose index, ventricular arrhythmias and major cardiovascular events in patients at high risk of sudden cardiac death
by: Yuan Gao, et al.
Published: (2024-10-01)

Reducing fluoroscopy time during cardioverter-defibrillator implantation, performed with considering of myocardium perfusion scintigraphy results in patients with coronary artery disease
by: T. A. Atabekov, et al.
Published: (2018-12-01)

URGENT CATHETER ABLATION OF THE ELECTRICAL STORM IN PATIENTS WITH IMPLANTED CARDIOVERTER-DEFIBRILLATOR
by: R. B. Tatarsky, et al.
Published: (2015-11-01)

Management of Catecholaminergic Polymorphic Ventricular Tachycardia
by: Ekaterina K. Kulbachinskaya, et al.
Published: (2024-05-01)

A Case Report on USG-Guided Stellate Ganglion Block in Refractory Ventricular Tachycardia
by: Anwesha Banerjee, et al.
Published: (2025-06-01)

Heart rate turbulence and T wave alternation in myocardial electrical instability diagnostics
by: A. E. Radzevich, et al.
Published: (2006-10-01)

Radiomic Cardiac MRI Signatures for Predicting Ventricular Arrhythmias in Patients With Nonischemic Dilated Cardiomyopathy
by: Amine Amyar, PhD, et al.
Published: (2025-04-01)

Validation of ACC/AHA and ESC Sudden Cardiac Death Risk Guidelines in Diverse Hypertrophic Cardiomyopathy Cohort: Stratification HCM Study
by: Murillo Oliveira Antunes, et al.
Published: (2024-12-01)

A new approach in cardioverter-defibrillator implantation in patients with coronary artery disease
by: Т. A. Atabekov, et al.
Published: (2019-04-01)

The results of surgical treatment of a patient with isolated left ventricular apical hypoplasia and left ventricular noncompaction
by: V. I. Skidan, et al.
Published: (2019-09-01)

How to Indicate Implantable Cardioverter‐Defibrillator in Patients With Malignancy
by: Naoya Kataoka, et al.
Published: (2025-08-01)

The role of cardiac MRI in risk stratification for sudden cardiac death in patients with hypertrophic cardiomyopathy
by: M. S. Ishchenko, et al.
Published: (2024-05-01)

Catheter ablation versus medical therapy for ventricular tachycardia in patients with ischemic heart disease: A systematic review and meta-analysis of randomized controlled trials
by: Ubaid Khan, et al.
Published: (2025-03-01)

Appropriate implantable cardioverter-defibrillator therapy triggered by heat stroke
by: Carlos Fernando Paz Mamani, et al.
Published: (2025-01-01)

Safety and Tolerability of Implanted Subcutaneous Cardioverter-Defibrillator Systems
by: A. V. Vereshchagina, et al.
Published: (2022-09-01)

Non-compaction cardiomyopathy. Part I: clinical and genetic heterogeneity and predictors of unfavorable prognosis
by: T. G. Vaikhanskaya, et al.
Published: (2020-12-01)

Clinical characteristics of various arrhythmogenic cardiomyopathy phenotypes in the pediatric population: a systematic review and meta-analysis
by: D. Yu. Alekseeva, et al.
Published: (2022-12-01)

PREVENTION OF SUDDEN CARDIAC DEATH BY IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS: ANALYSIS OF LARGE-SCALE CLINICAL TRIALS AND RECOMMENDATIONS OF EUROPEAN SOCIETY OF CARDIOLOGY (2015)
by: N. V. Melnik
Published: (2018-01-01)

Atrial Fibrillation and Ventricular Arrhythmias in ST Segment Elevation Myocardial Infarction: Possibilities of Pharmacotherapy and Non-Pharmacological Treatment
by: Yu. A. Bunin, et al.
Published: (2018-09-01)

POSSIBILITY AND NECESSITY OF CATHETER ABLATION OF VENTRICULAR ARRHYTHMIAS IN PATIENTS WITH ISCHEMIC HEART DISEASE AND IMPLANTED CARDIOVERTERDEFIBRILLATOR
by: G. A. Gromyko, et al.
Published: (2018-01-01)

Risk stratification of sudden cardiac death in heart failure patients: is left ventricular ejection fraction alone sufficient?
by: N. N. Ilov, et al.
Published: (2021-02-01)